RAC1 usually exerted its effect through activating its downstream signaling, thus we tested several possibly involved signaling and identified the mitogen-activated protein kinase (MAPK) signaling pathway as the downstream effector signaling of RAC1 in HCC cells. The gene discussed is RAC1; the disease is hepatocellular carcinoma.